Icecure Medical is trading at $1.63, down 5.78%, amid broad risk-off pressure on September 28 after President Trump rejected an Iranian proposal. - Reuters reported that oil prices climbed and Treasury yields rose following the rejection. - U.S. indexes also fell, reflecting renewed inflation and interest-rate concerns. - No new company-specific announcement was found; the latest major company news was China regulatory approval announced September 10.